Prediction and interpretation of the lipophilicity of small peptides
暂无分享,去创建一个
Alessia Visconti | Giulia Caron | Giuseppe Ermondi | Roberto Esposito | A. Visconti | G. Caron | G. Ermondi | Roberto Esposito
[1] P Buchwald,et al. Octanol-water partition: searching for predictive models. , 1998, Current medicinal chemistry.
[2] Fabrizio Giordanetto,et al. Oral druggable space beyond the rule of 5: insights from drugs and clinical candidates. , 2014, Chemistry & biology.
[3] Giulia Caron,et al. A comparison of calculated and experimental parameters as sources of structural information: the case of lipophilicity-related descriptors. , 2003, Mini reviews in medicinal chemistry.
[4] Yang Zhang,et al. I-TASSER: a unified platform for automated protein structure and function prediction , 2010, Nature Protocols.
[5] Peter Filzmoser,et al. Multivariate linear QSPR/QSAR models: Rigorous evaluation of variable selection for PLS , 2013, Computational and structural biotechnology journal.
[6] J. Johansson,et al. In vitro ADMET and physicochemical investigations of poly-N-methylated peptides designed to inhibit Abeta aggregation. , 2010, Bioorganic & medicinal chemistry.
[7] Stefano Moro,et al. Pharmaceutical Perspectives of Nonlinear QSAR Strategies , 2010, J. Chem. Inf. Model..
[8] Roman Rosipal,et al. Overview and Recent Advances in Partial Least Squares , 2005, SLSFS.
[9] P. Goodford. A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. , 1985, Journal of medicinal chemistry.
[10] I. Talavera,et al. Critical comparative analysis, validation and interpretation of SVM and PLS regression models in a QSAR study on HIV-1 protease inhibitors , 2009 .
[11] Corinna Cortes,et al. Support-Vector Networks , 1995, Machine Learning.
[12] Luhua Lai,et al. Calculating Partition Coefficients of Peptides by the Addition Method , 1999 .
[13] Pierre Tufféry,et al. PEP-FOLD: an online resource for de novo peptide structure prediction , 2009, Nucleic Acids Res..
[14] M. Khrestchatisky,et al. Synthetic therapeutic peptides: science and market. , 2010, Drug discovery today.
[15] F. Milletti,et al. Cell-penetrating peptides: classes, origin, and current landscape. , 2012, Drug discovery today.
[16] Matthew P. Jacobson,et al. Predicting and improving the membrane permeability of peptidic small molecules. , 2012, Journal of medicinal chemistry.
[17] J. J. Nestor,et al. The medicinal chemistry of peptides. , 2009, Current medicinal chemistry.
[18] Joseph E Cavanaugh,et al. Water-solvent partition coefficients and Delta Log P values as predictors for blood-brain distribution; application of the Akaike information criterion. , 2010, Journal of Pharmacy and Science.
[19] S. Wold,et al. PLS-regression: a basic tool of chemometrics , 2001 .
[20] T. Fujita,et al. Hydrophobicity of Di‐ and Tripeptides Having Unionizable Side Chains and Correlation with Substituent and Structural Parameters , 1989 .
[21] P. Carrupt,et al. Molecular fields in quantitative structure–permeation relationships: the VolSurf approach , 2000 .
[22] Kurt Hornik,et al. Misc Functions of the Department of Statistics (e1071), TU Wien , 2014 .
[23] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.
[24] Shigeo Abe. Support Vector Machines for Pattern Classification , 2010, Advances in Pattern Recognition.
[25] J. Dearden,et al. QSAR modeling: where have you been? Where are you going to? , 2014, Journal of medicinal chemistry.
[26] Jianhua Yao,et al. SVM approach for predicting LogP , 2006, Molecular Diversity.
[27] Alexander J. Smola,et al. Learning with kernels , 1998 .
[28] Hadar Benyamini,et al. Using peptides to study protein-protein interactions. , 2010, Future medicinal chemistry.
[29] D. Craik,et al. The Future of Peptide‐based Drugs , 2013, Chemical biology & drug design.
[30] R. Mannhold,et al. Calculation of molecular lipophilicity: state of the art and comparison of methods on more than 96000 compounds , 2009, Journal of pharmaceutical sciences.
[31] Horst Kessler,et al. Cilengitide: The First Anti-Angiogenic Small Molecule Drug Candidate. Design, Synthesis and Clinical Evaluation , 2010, Anti-cancer agents in medicinal chemistry.